SPIRIT: Study of the Patency of Spinal aRteries After the STABILISE Technique
Launched by ASSOCIACAO PARA INVESTIGACAO E DESENVOLVIMENTO DA FACULDADE DE MEDICINA - CETERA · Apr 16, 2024
Trial Information
Current as of July 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
BACKGROUND AND STUDY INTRODUCTION
Endovascular treatment emerged over the last decade as the standard of care for complicated acute type B aortic dissection and the first step is usually the deployment of a thoracic endograft (TEVAR) aiming to cover the entry tear. TEVAR may be enough to fix malperfusion syndromes but is frequently associated with late aortic dilatation and unfavorable remodeling \[1,2\]. The failure of simple TEVAR to solve malperfusion syndromes led to the development of adjunctive techniques like direct stenting of the occluded arteries, fenestration of the lamella or t...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients with type B dissection treated according to the STABILISE technique
- Exclusion Criteria:
- • Aortic rupture.
About Associacao Para Investigacao E Desenvolvimento Da Faculdade De Medicina Cetera
The Associação para Investigação e Desenvolvimento da Faculdade de Medicina - Cetera is a distinguished clinical trial sponsor dedicated to advancing medical research and innovation. Affiliated with a leading medical faculty, Cetera focuses on the design, execution, and management of clinical studies that aim to enhance healthcare outcomes. With a commitment to ethical standards and scientific rigor, the organization collaborates with healthcare professionals, researchers, and institutions to facilitate groundbreaking discoveries and translate findings into effective treatments. Through its robust infrastructure and expertise, Cetera plays a pivotal role in driving forward the frontiers of medical knowledge and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lisbon, , Portugal
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported